PHI with gastric ulcer

Read in German: PKV mit Magenulkus

How does this condition affect your private health insurance?

Magenulkus, or peptic ulcer, is an open sore that develops on the lining of the stomach (gastric ulcer), small intestine (duodenal ulcer), or esophagus. It typically results from an imbalance between stomach acid and digestive fluid protection, often caused by Helicobacter pylori (H. pylori) infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). Symptoms include burning stomach pain, bloating, nausea, and indigestion. If left untreated, complications such as bleeding, perforation, or obstruction can occur, requiring urgent medical attention. Diagnosis often involves endoscopy.

PKV Risk Assessment

High Probability of Rejection

However, some specialized PHI providers may insure you with a surcharge of up to 15%.

This is a preliminary assessment. For a detailed and binding risk assessment, .

Impact on Your Insurance Policy

Duration of Illness (Initial)

Several weeks with appropriate treatment, potentially longer without.

Duration of Illness (Lifetime)

Often recurrent without proper H. pylori eradication or cessation of NSAID use; can become a chronic condition.

Cost of Treatment (Initial)

Moderate (e.g., $500 - $3000 for diagnosis and initial medication, potentially higher with endoscopy and follow-up).

Cost of Treatment (Lifetime)

Variable, from moderate for a single occurrence to high if recurrent or complicated (e.g., $1000 - $15000+ depending on severity and need for surgery).

Mortality Rate

Low (<1%) for uncomplicated cases, but significantly increases (up to 5-10%) with severe complications like massive hemorrhage or perforation.

Risk of Secondary Damages

Moderate (e.g., 10-20% for bleeding, 1-2% for perforation, <1% for obstruction) if untreated or poorly managed.

Probability of Full Recovery

High (>90%) with appropriate H. pylori eradication, acid suppression therapy, and lifestyle changes.

Underlying Disease Risk

High for Helicobacter pylori infection (e.g., 50-70%), moderate for long-term NSAID use (e.g., 10-30%); rare for Zollinger-Ellison syndrome.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.